Literature DB >> 27235355

Schwann cell differentiation inhibits interferon-gamma induction of expression of major histocompatibility complex class II and intercellular adhesion molecule-1.

Robert P Lisak1, Beverly Bealmear2, Joyce A Benjamins3.   

Abstract

Interferon-gamma (IFN-γ) upregulates major histocompatibility complex class II (MHC class II) antigens and intercellular adhesion molecule-1 (ICAM-1) on Schwann cells (SC) in vitro, but in nerves of animals and patients MHC class II is primarily expressed on inflammatory cells. We investigated whether SC maturation influences their expression. IFN-γ induced MHC class II and upregulated ICAM-1; the axolemma-like signal 8-bromo cyclic adenosine monophosphate (8 Br cAMP) with IFN-γ inhibited expression. Delaying addition of 8 Br cAMP to SC already exposed to IFN-γ inhibited ongoing expression; addition of IFN-γ to SC already exposed to 8 Br cAMP resulted in minimal expression. Variability of cytokine-induced MHC class II and ICAM-1 expression by SC in vivo may represent the variability of signals from axolemma.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Axolemma; Cytokines; Demyelinating neuropathy; Interferon; Peripheral nervous system; Schwann cells

Mesh:

Substances:

Year:  2016        PMID: 27235355     DOI: 10.1016/j.jneuroim.2016.03.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

Review 1.  Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries.

Authors:  George D Bittner; Jared S Bushman; Cameron L Ghergherehchi; Kelly C S Roballo; Jaimie T Shores; Tyler A Smith
Journal:  J Neuroinflammation       Date:  2022-02-28       Impact factor: 8.322

2.  Coding transcriptome analyses reveal altered functions underlying immunotolerance of PEG-fused rat sciatic nerve allografts.

Authors:  Tyler A Smith; Cameron L Ghergherehchi; Haley O Tucker; George D Bittner
Journal:  J Neuroinflammation       Date:  2020-10-02       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.